PuriBlood Medical Co.,Ltd.(TW:6847)
NT$70.40-0.70 (-0.98%)
TW:6847
PuriBlood Medical Co.,Ltd. financials statements
NT$70.40
At close:-0.70 (-0.98%)
PuriBlood Medical Co.,Ltd. (6847) Financial Statements
PuriBlood Medical Co.,Ltd. Financial Overview
PuriBlood Medical Co.,Ltd.'s market cap is currently NT$1.19B. The company's EPS TTM is NT$-3.92; its P/E ratio is -17.96; PuriBlood Medical Co.,Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 82.33M | NT$ 110.67M | NT$ 125.27M | NT$ 137.44M | NT$ 54.59M |
| Gross Profit | NT$ 32.31M | NT$ 56.81M | NT$ 6.52M | NT$ 58.66M | NT$ 5.60M |
| Operating Income | NT$ -33.44M | NT$ -2.74M | NT$ -50.40M | NT$ 7.24M | NT$ -35.40M |
| EBITDA | NT$ -29.89M | NT$ 4.15M | NT$ -44.02M | NT$ 26.02M | NT$ -30.80M |
| Net Income | NT$ -39.00M | NT$ -5.37M | NT$ -51.59M | NT$ 16.53M | NT$ -38.02M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 60.43M | NT$ 86.61M | NT$ 117.48M | NT$ 99.50M | NT$ 131.87M |
| Total Assets | NT$ 236.68M | NT$ 259.15M | NT$ 265.51M | NT$ 320.50M | NT$ 265.60M |
| Total Debt | NT$ 51.04M | NT$ 51.84M | NT$ 51.64M | NT$ 56.61M | NT$ 30.48M |
| Net Debt | NT$ -9.39M | NT$ -34.77M | NT$ -65.84M | NT$ -42.89M | NT$ -101.39M |
| Total Liabilities | NT$ 96.47M | NT$ 83.75M | NT$ 84.35M | NT$ 87.47M | NT$ 49.11M |
| Stockholders' Equity | NT$ 140.21M | NT$ 175.40M | NT$ 181.16M | NT$ 233.03M | NT$ 216.50M |
| Cash Flow | |||||
| Free Cash Flow | NT$ -27.87M | NT$ -31.74M | NT$ 20.30M | NT$ -42.30M | NT$ -48.77M |
| Operating Cash Flow | NT$ -27.39M | NT$ -29.68M | NT$ 26.64M | NT$ -30.83M | NT$ -43.68M |
| Investing Cash Flow | NT$ 2.01M | NT$ -1.40M | NT$ -3.25M | NT$ -25.64M | NT$ -24.35M |
| Financing Cash Flow | NT$ -803.00K | NT$ 204.00K | NT$ -5.42M | NT$ 24.10M | NT$ 100.06M |
Currency in TWD

